CD8A and neoplasm: However, it now appears clear that engagement of inhibitory receptors such as CTLA-4, PD-1 and Tim-3, expressed on CD8+ tumour-infiltrating lymphocytes (TIL) with their respective ligands on target cells, is another critical constraint explaining the poor reactivity of these cells in the tumour immune context2.